SGLT2 inhibition by empagliflozin attenuates ectopic fat accumulation and improves cardiac index in parallel to ketone bodies production: the EMPAFAT study
Author(s) -
F. Maurice,
PierresYves Ancel,
E. Mayoux,
I. Abdesselam,
Frank Kober,
P. Darmon,
M. Grino,
Bénédicte Gaborit,
Monique Bernard,
Anne Dutour
Publication year - 2017
Publication title -
hal (le centre pour la communication scientifique directe)
Language(s) - English
Resource type - Conference proceedings
Subject(s) - empagliflozin , ketone bodies , index (typography) , medicine , chemistry , cardiology , computer science , endocrinology , metabolism , type 2 diabetes , diabetes mellitus , world wide web
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom